Healthcare Professionals Patients
ProAir HFA has the most preferred formulary coverage

ProAir® HFA gives your patients unmatched access

Widest formulary coverage of any albuterol HFA inhaler

ProAir® HFA is covered on nearly 93% of commercial formularies. That’s the widest commercial formulary coverage of any albuterol inhaler. The availability and affordability of ProAir® HFA helps support your clinical efforts.1

Most preferred formulary coverage

More than 80% of commercial formularies give ProAir® HFA preferred coverage. In fact, ProAir® HFA has the most preferred formulary coverage of any albuterol HFA inhaler. That means more of your patients pay less for their medication.1

Reference
  1. Aggregated Reports, Formulary Position and Restrictions, ProAir HFA Market. Business One Technologies; April 30, 2010.
ProAir® HFA (albuterol sulfate) Inhalation Aerosol is indicated in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.

Important Safety Information

  • Inhaled albuterol sulfate can produce paradoxical bronchospasm that may be life-threatening. It should be recognized that paradoxical bronchospasm, when associated with inhaled formulations, frequently occurs with the first use of a new canister.
  • Fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs in patients with asthma.
  • ProAir HFA, as with all sympathomimetic amines, should be used with caution in patients with cardiovascular disorders (especially coronary insufficiency, cardiac arrhythmias, and hypertension), convulsive disorders, hyperthyroidism, and diabetes.
  • Potential drug interactions can occur with beta-blockers, diuretics, digoxin, or monoamine oxidase inhibitors, and tricyclic antidepressants.
  • Do not exceed the recommended dose.
  • Adverse events, which occurred at an incidence rate of at least 3% with ProAir HFA, include headache, tachycardia, pain, dizziness, pharyngitis, and rhinitis.
©2011 Teva Respiratory, LLC. This site is intended for U.S. residents only. All Rights Reserved.
ProAir® HFA is a registered trademark of Teva Respiratory, LLC.
EIB Active™ is a trademark of Teva Respiratory, LLC. EIB Active™ is sponsored by Teva Respiratory.

101446